Milou van Heuckelum1, Cornelia H M van den Ende1,2, Anne E J Houterman3, Charlotte P M Heemskerk4, Sandra van Dulmen5,6,7, Bart J F van den Bemt1,3. 1. Departments of Rheumatology and Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands. 2. Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands. 3. Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands. 4. Department of Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands. 5. NIVEL (Netherlands Institute for Health Services Research), Utrecht, The Netherlands. 6. Faculty of Health Sciences, Buskerud and Vestfold University College, Drammen, Norway. 7. Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Abstract
OBJECTIVE: This study aims to assess the efficacy of Electronic Monitoring Feedback (EMF) as an intervention to improve medication adherence (i.e. dose- or full adherence) and clinical outcomes in adult patients. METHODS: A systematic search was performed in Medline, EMBASE, PsycINFO and Web of Science and reported according to the PRISMA guidelines. Randomised controlled trials (RCTs) comparing EMF with usual care were identified to systematically summarise the evidence for use of EMF in improving medication adherence and clinical outcomes. The GRADE approach was used to assess the quality of the body of evidence. RESULTS: Of 9,993 initially-identified studies, ten studies (four of high-quality and six of low-quality) were included. The sample size of the studies included varied from 18 to 205 patients. Four of the six studies (66.7%) reported a significant positive effect of EMF on mean dose adherence levels, whereas a significant positive effect of EMF on mean full adherence levels was found in all of the included studies (100%, five out of five of the studies included). A significant positive effect of EMF on clinical outcomes was reported in one of the seven studies included. The overall effect of EMF on mean dose- and full adherence was positive and the overall effect of EMF on clinical outcomes was inconclusive. CONCLUSION: Considering the positive effect of EMF on medication adherence, EMF might be a promising intervention to enhance medication adherence. However, the effect of EMF on clinical outcomes was inconclusive. Prior to implementing EMF in clinical practice, future research with high-quality studies (e.g. adequate sample sizes, follow-up periods and no interfering co-interventions) is required to examine the (long-term) efficacy of EMF.
OBJECTIVE: This study aims to assess the efficacy of Electronic Monitoring Feedback (EMF) as an intervention to improve medication adherence (i.e. dose- or full adherence) and clinical outcomes in adult patients. METHODS: A systematic search was performed in Medline, EMBASE, PsycINFO and Web of Science and reported according to the PRISMA guidelines. Randomised controlled trials (RCTs) comparing EMF with usual care were identified to systematically summarise the evidence for use of EMF in improving medication adherence and clinical outcomes. The GRADE approach was used to assess the quality of the body of evidence. RESULTS: Of 9,993 initially-identified studies, ten studies (four of high-quality and six of low-quality) were included. The sample size of the studies included varied from 18 to 205 patients. Four of the six studies (66.7%) reported a significant positive effect of EMF on mean dose adherence levels, whereas a significant positive effect of EMF on mean full adherence levels was found in all of the included studies (100%, five out of five of the studies included). A significant positive effect of EMF on clinical outcomes was reported in one of the seven studies included. The overall effect of EMF on mean dose- and full adherence was positive and the overall effect of EMF on clinical outcomes was inconclusive. CONCLUSION: Considering the positive effect of EMF on medication adherence, EMF might be a promising intervention to enhance medication adherence. However, the effect of EMF on clinical outcomes was inconclusive. Prior to implementing EMF in clinical practice, future research with high-quality studies (e.g. adequate sample sizes, follow-up periods and no interfering co-interventions) is required to examine the (long-term) efficacy of EMF.
Authors: Helmut Brath; Jürgen Morak; Thomas Kästenbauer; Robert Modre-Osprian; Hermine Strohner-Kästenbauer; Mark Schwarz; Willem Kort; Günter Schreier Journal: Br J Clin Pharmacol Date: 2013-09 Impact factor: 4.335
Authors: Gordon H Guyatt; Andrew D Oxman; Gunn Vist; Regina Kunz; Jan Brozek; Pablo Alonso-Coello; Victor Montori; Elie A Akl; Ben Djulbegovic; Yngve Falck-Ytter; Susan L Norris; John W Williams; David Atkins; Joerg Meerpohl; Holger J Schünemann Journal: J Clin Epidemiol Date: 2011-01-19 Impact factor: 6.437
Authors: Gordon H Guyatt; Andrew D Oxman; Victor Montori; Gunn Vist; Regina Kunz; Jan Brozek; Pablo Alonso-Coello; Ben Djulbegovic; David Atkins; Yngve Falck-Ytter; John W Williams; Joerg Meerpohl; Susan L Norris; Elie A Akl; Holger J Schünemann Journal: J Clin Epidemiol Date: 2011-07-30 Impact factor: 6.437
Authors: Faustinus Onyirimba; Andrea Apter; Susan Reisine; Mark Litt; Corliss McCusker; MaryLou Connors; Richard ZuWallack Journal: Ann Allergy Asthma Immunol Date: 2003-04 Impact factor: 6.347
Authors: Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart Journal: BMJ Date: 2015-01-02
Authors: Laura B Whiteley; Elizabeth M Olsen; Kayla K Haubrick; Enyonam Odoom; Nicholas Tarantino; Larry K Brown Journal: Curr HIV/AIDS Rep Date: 2021-06-21 Impact factor: 5.071
Authors: Lauren M Hill; Carol E Golin; Allison Pack; Jessica Carda-Auten; Deshira D Wallace; Sruthi Cherkur; Claire E Farel; Elias P Rosen; Monica Gandhi; Heather M Asher Prince; Angela D M Kashuba Journal: J Assoc Nurses AIDS Care Date: 2020 Jan-Feb Impact factor: 1.354
Authors: Shivan J Mehta; Kevin G Volpp; Andrea B Troxel; Susan C Day; Raymond Lim; Noora Marcus; Laurie Norton; Sophia Anderson; David A Asch Journal: J Gen Intern Med Date: 2019-08-08 Impact factor: 5.128
Authors: K Rivet Amico; Jane C Lindsey; Michael Hudgens; Ronald Dallas; Keith J Horvath; Amanda Dunlap; Rachel Goolsby; Megan Mueller Johnson; Barbara Heckman; Jessica Crawford; Elizabeth Secord; Murli Purswani; Danial Reirden; Mobeen Rathore; Lisa-Gaye Robinson; Aditya H Gaur Journal: AIDS Behav Date: 2022-06-07
Authors: I Marion Sumari-de Boer; Kennedy M Ngowi; Tolbert B Sonda; Francis M Pima; Lyidia V Masika Bpharm; Mirjam A G Sprangers; Peter Reiss; Blandina T Mmbaga; Pythia T Nieuwkerk; Rob E Aarnoutse Journal: J Acquir Immune Defic Syndr Date: 2021-08-15 Impact factor: 3.771
Authors: Pedro Vieira-Marques; Rute Almeida; João F Teixeira; José Valente; Cristina Jácome; Afonso Cachim; Rui Guedes; Ana Pereira; Tiago Jacinto; João A Fonseca Journal: Methods Inf Med Date: 2021-04-27 Impact factor: 2.176
Authors: William R Nardi; Eric B Loucks; Stacey Springs; Don Operario; Ian M Kronish; Brandon A Gaudiano; Shufang Sun Journal: J Psychosom Res Date: 2021-07-26 Impact factor: 4.620